Nature Neuroscience, Published online: 08 September 2026; doi:10.1038/s41593-026-02418-6Although Alzheimer’s disease (AD) is a disease of the brain, we demonstrate that it disrupts myeloid cell production in the bone marrow via a type I interferon signal, preventing protective monocyte-derived macrophages from reaching the brain. Blocking this signal in the 5xFAD mouse model of amyloidosis restored healthy monocyte output and alleviated disease manifestations, highlighting the peripheral immune system as a therapeutic target.
If you do not see content above, kindly GO TO SOURCE.
Not all publishers encode content in a way that enables republishing at Neuro.vip.
This post is Copyright: | September 8, 2026
NeuroScience